1-4 of 4
Cheol Soo Kim
Close
Save search
Follow your search
Access your saved searches in your account
Would you like to receive an alert when new items match your search?
Close Modal
Sort by
Journal Articles

The Effect of Bortezomib On Bone Metabolism of Patients with Multiple Myeloma: a Korean Multicenter Prospective Study.

Chang-Ki Min, MD, Seok Jin Kim, MD, Je-Jung Lee, MD, Cheolwon Suh, MD, Jin Seok Kim, MD, Sung-Soo Yoon, MD, Byung Soo Kim, MD, Hye Jin Kang, MD, Young Jin Choi, MD, Cheol Soo Kim, MD, Yang Soo Kim, MD, Jae-Yong Kwak, MD, Yoo Jin Kim, MD, Young Don Joo, MD, Yeung-Chul Mun, MD, Deog Yeon Jo, MD, Joon Seong Park, MD, Chi-Young Park, MD, Sung Hyun Kim, MD
Journal: Blood
Blood (2009) 114 (22): 4871.
https://doi.org/10.1182/blood.V114.22.4871.4871
Published: 2009
Journal Articles

Induction Therapy with “3+7” Chemotherapy Plus ATRA Followed by Consolidations with Three Courses of Idarubicin Alone and Maintenance Therapy with ATRA in Newly Diagnosed Acute Promyelocytic Leukemia (APL) Has An Excellent Leukemia-Free Survival but Minimal Toxicity in Low and Intermediate Risk Groups.

Moon-Young Choi, Yeung-Chul Mun, Se Hoon Park, Eun Kyung Cho, Jae Hoon Lee, Deog Yeon Jo, Inho Kim, Soo-Mee Bang, Sung-Soo Yoon, Seonyang Park, Byoung Kook Kim, Hawk Kim, Young Joo Min, Jae Hoo Park, Jong Jin Seo, Hyung Nam Moon, Moon Hee Lee, Cheol Soo Kim, Won Sik Lee, Young Don Joo, So Young Chung, Doyeun Oh, Dae Young Zang, Kyung Hee Lee, Myung Soo Hyun, Hong Suk Song, Heung Sik Kim, Sung Hyun Kim, Hyuk Chan Kwon, Hyo Jin Kim, Kyung Tae Park, Jin Seok Ahn, Yeon Hee Park, Myung Ju Ahn, Sung Hwa Bae, Hun-Mo Ryoo, Jung-Hye Choi, Hwi-Joong Yoon, Seung-Hyun Nam, Bong-Seog Kim, Thad T. Ghim, Chu-Myong Seong
Journal: Blood
Blood (2009) 114 (22): 2072.
https://doi.org/10.1182/blood.V114.22.2072.2072
Published: 2009
Journal Articles

Sequential VAD (Vincristine, Adriamycin, Dexamethasone) and VTD (Bortezomib, Thalidomide, Dexamethasone) Induction Followed by High-Dose Therapy with Autologous Stem Cell Transplantation and Maintenance Treatment with Bortezomib for Newly Diagnosed Multiple Myeloma: Final Analysis of Phase II Trial.

Sung-Soo Yoon, Hye Jin Kim, Joo Seop Chung, HyeonSeok Eom, Jun-Ho Jang, Hye Jin Kang, Cheol Soo Kim, Kihyun Kim, Dongsoon Lee, Jae Hoon Lee, Junglim Lee, Sang Jae Lee, Yoo Hong Min, Chu-Myong Seong, Sang-Kyun Sohn, Cheolwon Suh, Jong-Ho Won
Journal: Blood
Blood (2008) 112 (11): 3330.
https://doi.org/10.1182/blood.V112.11.3330.3330
Published: 2008
Journal Articles

Sequential VAD (Vincristine, Adriamycin, Dexamethasone) and VTD (VELCADE®, Thalidomide, Dexamethasone) Induction Followed by High-Dose Therapy with Autologous Stem Cell Transplantation and Maintenance Treatment with VELCADE for Newly Diagnosed Multiple Myeloma: Interim Results of Phase II Trial.

Sung-Soo Yoon, MD, Hye Jin Kim, M.D., Dong Soon Lee, M.D., Hyeon Seok Eom, M.D., Jun Ho Jang, M.D., Ju Seup Chung, M.D., Hye Jin Kang, M.D., Cheol Soo Kim, M.D., Kihyun Kim, M.D., Jae Hoon Lee, M.D., Sang Jae Lee, M.D., Yu Hong Min, M.D., Chu Myong Seong, M.D., Sang Kyun Sohn, M.D., Cheolwon Suh, M.D., Jong Ho Won, M.D.
Journal: Blood
Blood (2007) 110 (11): 952.
https://doi.org/10.1182/blood.V110.11.952.952
Published: 2007